S&P 500 · Health Care · USD · FY end 2025-12-31
Thermo Fisher Scientific (TMO) financials — revenue, earnings, margins, balance sheet, cash flow and dividends. 10-year history sourced from SEC filings.
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| FY2025 | 44.56B | 6.70B | 17.74 | 6.29B |
| FY2024 | 42.88B | 6.34B | 16.53 | 7.27B |
| FY2023 | 42.86B | 5.96B | 15.45 | 6.93B |
| FY2022 | 44.91B | 6.96B | 17.63 | 6.91B |
| FY2021 | 39.21B | 7.73B | 19.46 | 6.79B |